A detailed history of Jpmorgan Chase & CO transactions in Zynex Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 40,985 shares of ZYXI stock, worth $320,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,985
Previous 39,667 3.32%
Holding current value
$320,092
Previous $369,000 9.49%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$7.19 - $10.31 $9,476 - $13,588
1,318 Added 3.32%
40,985 $334,000
Q2 2024

Aug 12, 2024

SELL
$8.63 - $12.56 $151,482 - $220,465
-17,553 Reduced 30.68%
39,667 $369,000
Q1 2024

May 10, 2024

BUY
$9.86 - $13.74 $177,785 - $247,745
18,031 Added 46.01%
57,220 $707,000
Q4 2023

Feb 12, 2024

SELL
$7.1 - $10.89 $773,651 - $1.19 Million
-108,965 Reduced 73.55%
39,189 $426,000
Q3 2023

Nov 14, 2023

BUY
$6.95 - $9.89 $765,014 - $1.09 Million
110,074 Added 289.06%
148,154 $1.19 Million
Q2 2023

Aug 11, 2023

SELL
$8.59 - $14.56 $1.14 Million - $1.93 Million
-132,488 Reduced 77.67%
38,080 $365,000
Q1 2023

May 18, 2023

BUY
$9.53 - $16.8 $157,387 - $277,452
16,515 Added 10.72%
170,568 $2.05 Million
Q1 2023

May 11, 2023

SELL
$9.53 - $16.8 $97,968 - $172,704
-10,280 Reduced 6.26%
154,053 $1.85 Million
Q4 2022

Feb 13, 2023

SELL
$8.71 - $14.28 $127,218 - $208,573
-14,606 Reduced 8.16%
164,333 $2.29 Million
Q3 2022

Nov 14, 2022

SELL
$7.19 - $9.91 $3.22 Million - $4.43 Million
-447,380 Reduced 71.43%
178,939 $1.62 Million
Q2 2022

Aug 11, 2022

BUY
$5.78 - $8.87 $2.34 Million - $3.6 Million
405,396 Added 183.5%
626,319 $5 Million
Q1 2022

May 11, 2022

BUY
$5.14 - $9.35 $146,053 - $265,680
28,415 Added 14.76%
220,923 $1.38 Million
Q4 2021

Feb 10, 2022

BUY
$8.71 - $13.77 $102,542 - $162,114
11,773 Added 6.51%
192,508 $1.92 Million
Q3 2021

Nov 12, 2021

BUY
$10.35 - $15.65 $1.87 Million - $2.83 Million
180,735 New
180,735 $2.06 Million

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $293M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.